Currently, both Globus Medical and Penumbra are holding a Zacks Rank of # 2 (Buy). Investors should feel comfortable knowing that both of these stocks have an improving earnings outlook since the ...

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Their smid-cap selections feature Globus Medical, Penumbra (NYSE:PEN), and Insulet (NASDAQ:PODD) Corporation. They believe that stocks like DexCom (NASDAQ:DXCM), Medtronic (NYSE:MDT), and Edwards ...

Analysts expect Penumbra to report an earnings per share (EPS) of $0.67. The announcement from Penumbra is eagerly ...

Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the ...

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed ...